semaglutide and dementia Taking Could Cut Risk Nearly In Half, Case Western Study Shows Weight-loss Drug Ozempic Cuts Dementia

Ozempic (semaglutide 0.25 mg to 2.0 mg) is FDA-approved only for type 2 diabetes, not for weight management

Missing doses or injecting too frequently can affect the medications efficacy and safety

How often should you get B12 injections

Truveta provides access to continuously updated and linked electronic health record (EHR) data from a collective of 30 US health care systems

Curr Alzheimer Res 2011, 8: 156163

People may microdose GLP-1 medications for many reasons, including: They have hit their target weight goal They have concerns about the cost of the medications They are sensitive to the side effects of the medications They want to just suppress their appetite They are worried about the supply of the medications Microdosing GLP-1 medications can come with real risks, including: Inaccurate doses Reduced effectiveness Unpredictable outcomes Possibility of regaining weight No data on the long-term effects of microdosing Minimal oversight Large clinical trials have confirmed that the standard GLP-1 doses work well when helping people lose weight and manage Type 2 diabetes